Biogen Pharmachem Industries Ltd Share Price

Finance

BSE: 531752 Small Cap ISIN: INE703D01023

As on 15 July 2026 at 00:43 IST

₹0.34

+ 0.00

(0.00%)

Sell Buy

Over 1 Month

-10.53%

Over 6 Months

-46.03%

Over 1 Year

-59.04%

Over 3 Years

-39.29%

Biogen Pharmachem Industries Ltd Summary

Close ₹0.34

Open ₹0.35

High ₹0.35

Low ₹0.33

Volume 30,63,162

Net Turnover (in Cr) ₹0.1

52Wk High ₹0.93

52Wk Low ₹0.32

52Wk High / Low

0.32

0.93

Biogen Pharmachem Industries Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹35.80

EPS (TTM) 0.01

Book Value (BV) 0.94

Div. Yield -

P/E (TTM) 34

Price/Book Value 0.36

Delivery % 51.35 %

Face Value 1

Key Ratios

PE Ratio -

PB Ratio 1.12

EV to Sales 50.53

PEG Ratio -

ROA -0.32

ROE -

Debt-Equity -

Net Profit Margin -24.17

Operating Profit Margin -24.17

Biogen Pharmachem Industries Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1.20	2.38	0.91	2.48	1.62
Total Expenses	1.49	0.45	0.46	2.49	3.23
Profit Before Tax	-0.29	1.93	0.46	-0.01	-1.60
Profit After Tax	-0.29	1.93	0.46	-0.01	-1.60
Operating Profit After Depreciation	-0.29	1.93	0.46	-0.01	-1.60

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	-	-	-	-	-
Total Non Current Assets	89.35	56.73	54.67	53.02	51.69
Total Current Assets	2.67	0.09	0.15	1.93	2.56
Total Assets	92.02	56.82	54.83	54.95	54.25
Total Shareholder's Fund	91.93	56.52	54.59	54.13	54.14

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-1.08	1.94	1.70	1.40	3.95
Net Cash Used In Investing Activities	-32.62	-2.06	-1.66	-1.32	-3.64
Net Cash Used In Financing Activities	35.70	-	-	-	-0.31

No data available

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	0.58	0.54	-	-	1.35
Total Expenses	0.94	0.08	0.39	0.20	0.17
Profit Before Tax	-0.36	0.46	-0.49	1.34	1.18
Profit After Tax	-0.36	0.46	-0.49	1.34	1.18
Operating Profit after Depreciation	-0.36	0.46	-0.49	1.34	1.18

Biogen Pharmachem Industries Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 0.33

S2 0.32

S3 0.31

Pivot 0.34

R1 0.35

R2 0.36

R3 0.37

Moving Average

20 SMA 0.36

50 SMA 0.40

100 SMA 0.47

200 SMA 0.58

Biogen Pharmachem Industries Ltd Corporate Actions

No available data

AGM Date: 18 Sep 2021

AGM 18/09/2021 Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Monday, September 13, 2021 to Saturday, September 18, 2021 (both days inclusive) for taking record of the Members of the Company for the purpose of Annual General Meeting of the Company to be held on September 18, 2021.. You are requested to take note of the above and bring this to the notice of all concerned. Thanking you. Proceedings of 26th Annual General Meeting of the Company held on 18th September2021. 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2021 and Reports of the Directors and Auditors thereon. 2. Ordinary Resolution for appointment of MR. UDAYBHAI PATEL as Director of the Company who retires by rotation and being eligible offers him-self for re-appointment. 3. Ordinary Resolution for Appointment of Statutory Auditor and fix their remuneration. 4. Special Resolution for Appointment of Mr. AKSHAY MAKADIYA as Wholetime Director and Chief Financial Officer of the Company. 5. Ordinary Resolution for Appointment of Ms. MANISHABEN MUCHHALA as an Independent Director of the Company. 6. Ordinary Resolution for Appointment of MR. NIRAJ VAGHELA as an Independent Director of the Company. The above businesses were transacted and passed by the shareholders at Annual General Meeting. Thanking You. (As Per BSE Announcement Dated on 9/18/2021 1:37:28 AM) Biogen Pharmachem Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 20.09.2021)

AGM Date: 27 Sep 2022

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of Annual General Meeting of the company to be held on 27.09.2022 This is for your information and records. Thanking you, Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, September 21, 2022 to Tuesday, September 27, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of Annual General Meeting of the Company to be held on September 27, 2022. You are requested to take note of the above and bring this to the notice of all concerned. Thanking you, In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the following businesses were transacted at the 27th Annual General Meeting of the Company held on Tuesday the 27th September 2022 at 11:00 A.M. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2022 and Reports of the Directors and Auditors thereon. 2. Special Resolution for appointment of MR. NIRAJ VAGHELA (DIN NO.: 09096576) as Wholetime Director and Chief Financial Officer of the Company. 3. Ordinary Resolution for Appointment of Mr. CHANDRAKANT GOVINDBHAI PARMAR (DIN: 09406801) as an Independent Director of the Company. 4. Ordinary Resolution for Appointment of Ms. MANJULABEN PARMAR (DIN: 09420512), as an Independent Director of the Company. (As Per BSE Announcement dated on 27.09.2022) Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the voting results of the business transacted at the Annual General Meeting of the Company held on Tuesday the 27th September 2022 at 11:00 A.M through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM').in the prescribed format. Kindly take note of the above. Thanking you. (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 PFA (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 28 Sep 2024

AGM 28/09/2024 PFA (As Per BSE Announcement Dated on 28.09.2024)

AGM Date: 25 Sep 2025

AGM 25/09/2025 PFA (As per BSE Announcement Dated on 25/08/2025) PFA (As Per BSE Announcement Dated on:25.09.2025) PFA (As Per Bse Announcement dated on 26/09/2025)

Biogen Pharmachem Industries Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Bajaj Finance Ltd	₹870.30	₹5,41,844.80
Bajaj Finserv Ltd	₹1,645	₹2,63,290.47
Shriram Finance Ltd	₹886.35	₹2,08,550.63
ICICI Prudential Asset Management Co Ltd	₹3,210	₹1,58,656.98
Jio Financial Services Ltd	₹228	₹1,50,551.63

Biogen Pharmachem Industries Ltd Top Mutal Funds Invested

No data available

Biogen Pharmachem Industries Ltd News

Biogen Pharmachem Industries to table results

On 14 May 2026

05 May 2026, 10:32 am

Biogen Pharmachem Industries to consider Bonus Issue

On 23 March 2026

24 Feb 2026, 09:52 am

Biogen to consider proposal of bonus issue on 23 Mar

24 Feb 2026, 09:07 am

Biogen Pharmachem Industries to convene board meeting

On 3 February 2026

20 Jan 2026, 09:59 am

Biogen Pharmachem Industries to discuss results

On 7 November 2025

31 Oct 2025, 10:03 am

Biogen Pharmachem Industries Ltd Stock Analysis

Annual revenue for Biogen Pharmachem Industries Ltd decreased by 49.71% to ₹1.20 crore in FY 2025 from ₹2.38 crore in FY 2024.
Annual Net Profit for Biogen Pharmachem Industries Ltd decreased by 115.16% to ₹-0.29 crore in FY 2025 from ₹1.93 crore in FY 2024.
Promoter Shareholding in Biogen Pharmachem Industries Ltd remains unchanged by 0.00% in the most recent quarter, from 0% in March 2026 to 0% in May 2026.
Biogen Pharmachem Industries Ltd delivered a 1-year return of -59.04% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Biogen Pharmachem Industries Ltd share price moved remains unchanged by 0.00% from its previous close of INR ₹0.34. The latest Biogen Pharmachem Industries Ltd share price is INR ₹0.34.
Biogen Pharmachem Industries Ltd share price today has been at a low of 0.33 and a high of 0.34. Over the past 52 weeks, the Biogen Pharmachem Industries Ltd share price has seen a low of 0.32 and a high of 0.93.